GBM cells were preincubated either with azemiopsin, a selective competitive antagonist of muscle-type nAChR; with α-conotoxin [A10L]PnIA, which selectively blocks α7 nAChR; or with α-conotoxin RgIA, which inhibits α9 nAChR. This evidence concerns the gene CHRNA7 and glioblastoma.